EMA prepares clinical-trials system for proposed Biotech Act


The proposal would affect about 70% of CTIS functionality, requiring investment in the current system alongside plans for a new platform.
EMA is preparing changes to the Clinical Trials Information System (CTIS) for the proposed Biotech Act. In an update published on 1 October, the agency said the proposal’s changes to the authorisation and supervision of clinical trials would affect approximately 70% of the system’s current functionality.
CTIS is the single system used across all EU member states to support the Clinical Trials Regulation. It supports the authorisation and management of clinical trials—studies that test treatments in people—and collaboration between countries. EMA says CTIS has supported more than 14,000 European trials since its launch in 2022 and receives more than 200 new trial applications each month.
A modernisation initiative began in 2025 to prepare CTIS for growing numbers of trial submissions. The proposed legislation would also require changes to how the system handles assessments and ongoing trials, rather than simply increasing its capacity.
According to EMA, CTIS would need to support the following changes:

These are proposed changes, not rules already in force. EMA has not specified how much shorter the accelerated assessment timelines would be.
The European Commission adopted the Biotech Act proposal in December 2025, but the legislation remains under discussion in the European Council and Parliament. EMA described the legislative timetable as ambitious: the first changes to the Clinical Trials Regulation could enter into force in early 2028. That is a possible timetable, not an adopted deadline.
EMA’s management board wants key CTIS functions ready as early as possible and in time for adoption of the Act. The agency says this requires immediate investment in the current platform. Separately, it plans to deliver all the clinical-trial functionality envisaged by the Act through a new CTIS platform, with work scheduled to begin in early 2027.
EMA has not specified investment amounts. A detailed roadmap for delivering the new functions, including their resource implications, is due to be presented to the management board in December 2026.
NASA says Otter will begin inspecting up to four inactive objects in early 2027, testing navigation and propulsion without docking or removing debris.
3 min

The one-time payments are automatic, but customers of state-run insurance exchanges are excluded even if they paid full price.
2 min

The reported 2031 requirement falls from about 50 to 35 miles per gallon across vehicle fleets. Lower purchase prices, if achieved, could come with higher fuel bills.
2 min